article thumbnail

International Women’s Day: Female life science leaders

Drug Discovery World

For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. The life sciences sector has traditionally outperformed others when it comes to attracting women to its workforce.

article thumbnail

Coordinating the Cell Journey: Essentials in Early Clinical Development

PPD

The role of the clinical logistics monitor (CLM) is a focal point of contact and an escalation point to the internal and external teams. Explore our early development services LEARN MORE The post Coordinating the Cell Journey: Essentials in Early Clinical Development appeared first on PPD Inc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Comment: Drug discovery and the International Day of Action for Women’s Health

Drug Discovery World

The International Day of Action for Women’s Health has been celebrated on 28 May every year since 1987. Its lead therapeutic candidate, VMB-100, is currently undergoing advanced preclinical development activities and has demonstrated first-in-class potential for treatment of SUI in a pre-clinical animal model.

article thumbnail

UK-Dutch alliance to strengthen early clinical oncology research

Drug Discovery World

Both parties will have the opportunity to identify and nominate potential projects for clinical development. In particular, the alliance will focus on projects featuring a novel, promising, academic-derived agent which has the potential to address a high unmet clinical need.

Research 130
article thumbnail

Merck Announces Retirement of Dr. Roy D. Baynes; Dr. Eliav Barr Appointed Head of Global Clinical Development and Chief Medical Officer

The Pharma Data

Baynes, head of Global Clinical Development (GCD) and Chief Medical Officer, Merck Research Laboratories (MRL), will be retiring from Merck in July. He also led the expansion of Merck’s research and development in China and Japan. “It Baynes will be succeeded by Dr. Eliav Barr, senior vice president, Global Clinical Development.

article thumbnail

New drug candidate for multiple sclerosis shows promise in Phase I trial

Drug Discovery World

FSD Pharma has dosed the first cohort of patients in its Phase I clinical trial evaluating Lucid-MS for the treatment of multiple sclerosis (MS).

Trials 221
article thumbnail

AI drug discovery company closes $200m Series B financing

Drug Discovery World

A Series B financing round has raised Genesis Therapeutics’ total capital to over $280 million, which will be used to bring the company’s artificial intelligence (AI)-enabled pipeline into clinical development.

Drugs 130